Evidence map›Paper›PMID 19672320›Full record

ArticleExpert opinion on drug discovery2008

Advances in the Development and Application of Computational Methodologies for Structural Modeling of G-Protein Coupled Receptors.

Juan Carlos Mobarec, Marta Filizola

Abstract read
In one paragraph

Article in Expert opinion on drug discovery, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Juan Carlos MobarecDepartment of Structural and Chemical Biology, Mount Sinai School of Medicine, Icahn Medical Institute Building, 1425 Madison Avenue, Box 1677, New York, NY 10029-6574, Tel: 212-241-8634;
Marta Filizola

Funding

OPIOID RECEPTOR OLIGOMERIZATION: PREDICTION & VALIDATIONR01DA020032 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI FILIZOLA, MARTA · 2006 to 2010
$1.5M
INFORMATICS OF GPCR DIMERS IN DRUG ABUSE MECHANISMSR21DA017976 · NIDA · WEILL MEDICAL COLL OF CORNELL UNIV · PI FILIZOLA, MARTA · 2005 to 2009
$1.3M
NIDA NIH HHS R01 DA020032NIDA NIH HHS R21 DA017976
6 · The paper itself

Abstract

backgroundDespite the large amount of experimental data accumulated in the past decade on G-protein coupled receptor (GPCR) structure and function, understanding of the molecular mechanisms underlying GPCR signaling is still far from being complete, thus impairing the design of effective and selective pharmaceuticals.

objectiveUnderstanding of GPCR function has been challenged even further by more recent experimental evidence that several of these receptors are organized in the cell membrane as homo- or hetero-oligomers, and that they may exhibit unique pharmacological properties. Given the complexity of these new signaling systems, researcher's efforts are turning increasingly to molecular modeling, bioinformatics and computational simulations for mechanistic insights of GPCR functional plasticity.

methodsWe review here current advances in the development and application of computational approaches to improve prediction of GPCR structure and dynamics, thus enhancing current understanding of GPCR signaling. RESULTS/

conclusionsModels resulting from use of these computational approaches further supported by experiments are expected to help elucidate the complex allosterism that propagates through GPCR complexes, ultimately aiming at successful structure-based rational drug design.

Identifiers

PMID19672320
PMCPMC2723956

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.